78 歲的張先生是慢性阻塞性肺病的患者,過去一年內,由於發作頻繁,每天都需要使..-阿摩線上測驗
1F
|
2F
|
3F Chris 大二下 (2020/05/12)
In particular alendronate or risedronate, are the first-line drugs for the prevention and treatment of glucocorticoid-induced bone loss. The dose and the duration of glucocorticoid therapy should be as low as possible because even what are thought to be replacement doses or chronic inhaled glucocorticoids can cause bone loss. Alternative therapy should be used whenever possible. |